Epithelioid Mesothelioma

Epithelioid (or epithelial) mesothelioma is the most common cell type of this cancer. It also has the best prognosis (health outlook) since it doesn’t spread as quickly as the other two mesothelioma cell types. Learn more about epithelial mesothelioma and get personalized medical guidance for you or a loved one.

Medically reviewed by: Mark Levin, MD

Last updated:

What Is Epithelioid Mesothelioma?

Epithelioid mesothelioma is one of the three cell types of malignant mesothelioma. The other cell types are sarcomatoid and biphasic.

Over 50% of patients diagnosed with mesothelioma have the epithelioid cell type, according to the American Cancer Society (ACS).

Specially trained doctors called pathologists can identify epithelial mesothelioma cells by reviewing biopsy samples under a microscope.

Epithelioid mesothelioma cells are identified by their:

  • Clearly visible nucleus
  • Slower movement
  • Square, cube, long, or flat shape
  • Tendency to stick together

Illustration showing characteristics of epithelial mesothelioma cells: cube shaped, clumped together, and a visible nucleus
Epithelioid patients generally have a better prognosis than patients with other mesothelioma cell types. This is because epithelioid tumors spread (metastasize) slower and are easier to treat.

Get our Free Mesothelioma Guide to learn more about this cell type and what treatment options are available.

Mesothelioma Guide Images
Get Your Free 2025 Mesothelioma Guide
  • Symptoms & staging
  • Average prognosis
  • Life-extending treatments

Get Your Free Guide

What Causes Epithelioid Mesothelioma Cancer?

Asbestos exposure causes epithelioid mesothelioma.

When asbestos-containing products are disturbed or damaged, tiny fibers can be released into the air. When you breathe in or swallow these fibers, they can settle in the lining of the lungs or abdomen, leading to scarring and inflammation.

Over 10 to 50 years, this irritation can damage healthy epithelial cells, eventually leading to mesothelioma cancer.

Asbestos was used in various industries in the U.S. military up until the early 1980s, so many people with mesothelioma today are veterans and retired blue-collar workers.

“Asbestos was a critical material for World War II. It was used in insulation on the ships. It was used in gaskets, brake linings. That’s when my dad first started working, and that’s when he was first exposed.”
– Patricia, daughter of a veteran diagnosed with mesothelioma

Malignant Epithelioid Mesothelioma Symptoms

The symptoms of epithelioid mesothelioma depend on where the cancer is located in the body.

For example, cancer in the lining around the lungs (pleura) causes different symptoms than cancer in the abdominal lining (peritoneum).

Symptoms of Pleural Epithelioid MesotheliomaSymptoms of Peritoneal Epithelioid Mesothelioma
Chest painAbdominal pain
FatigueConstipation or diarrhea
Fluid buildup in the chest (pleural effusion)Fluid buildup in the abdomen (peritoneal ascites)
Shortness of breathNight sweats
Worsening coughUnexplainable weight loss

These symptoms usually get worse as the cancer spreads, so it’s important to see a specialist right away if you notice them. Contact our Patient Advocates so we can help you find a mesothelioma doctor in your area.

Epithelioid Mesothelioma Video Thumbnail

Epithelioid mesothelioma is the most common of three mesothelioma cell types, and it's also the easiest to treat since it doesn't spread as quickly. View Transcript.

Duration: 1 min 27 sec

Mesothelioma, a form of cancer that can develop in the lining of the lungs heart or abdomen has different cell types. Today we’ll shed some light on epithelioid mesothelioma, the most common cell type, about 70% of mesothelioma patients have the epithelioid or epithelial cell type. These patients have a distinct advantage when it comes to treatment options. Epithelial cells tend to grow relatively slowly allowing for more effective treatment strategies such as surgery, chemotherapy, and radiation. Thanks to this slower growth pattern, patients diagnosed with epithelioid mesothelioma have a better prognosis and higher survival rates compared to the other two cell types which are sarcomatoid and basic. If you or a loved one has been diagnosed with mesothelioma, it’s crucial to consult with a doctor who specializes in this rare cancer. They can provide you with the most up-to-date information on treatment options and guide you through your journey toward better health. Remember, early detection and Ely intervention are key to improving outcomes for mesothelioma patients. Stay informed, seek support, and explore all available resources to ensure the best possible care and support for yourself or your loved one. Remember, you are not alone in this fight. Help is just to call away. Contact us today to be connected with a patient advocate who can recommend doctors and treatments for epithelioid mesothelioma.

How Is Epithelial Mesothelioma Diagnosed?

Your doctor will use a series of imaging scans and tests to confirm an epithelioid mesothelioma diagnosis. Learn more about how mesothelioma is diagnosed below.

1. Physical Examination

The symptoms of epithelial mesothelioma can be vague, so they’re often mistaken for bronchitis, pneumonia, or digestive problems. A physical exam is a good first step to help your doctor rule out these more common conditions.

During the exam, your doctor will review your medical history and check your vital signs. They’ll use a stethoscope to listen to your breathing and check for signs of fluid buildup, which is an early sign of malignant pleural mesothelioma — the most common type of this cancer.

Your doctor might also check for any lumps or unusual masses around your chest and abdomen.

2. Imaging Scans

If your doctor sees or hears anything unusual during your physical exam, they can use imaging scans to look for tumors, nodules, scar tissue, or other signs of disease.

These may include:

  • Computed tomography (CT) scans
  • Magnetic resonance imaging (MRI) scans
  • Positron emission tomography (PET) scans
  • X-rays

Imaging tests are a key part of an epithelial mesothelioma diagnosis since they show details your doctor wouldn’t be able to see in a physical exam.

3. Blood Tests for Biomarkers

Some mesothelioma doctors may order blood tests as part of an epithelioid mesothelioma diagnosis. Certain blood tests can show biomarkers (indicators) associated with asbestos exposure.

For example, the American Society of Clinical Oncology (ASCO) recommends a specific biomarker test called immunohistochemistry staining. This test helps doctors identify certain proteins, such as calretinin, that are key indicators of mesothelioma.

4. Fluid or Tissue Biopsy

If imaging scans or blood tests show signs of cancer, your doctor will order a biopsy. A biopsy is the only way to confirm if you have epithelial mesothelioma.

After numbing the area with an anesthetic, your doctor will collect a small fluid or tissue sample through a tiny needle. You may feel some pressure during the procedure, which is normal.

A pathologist will then look at the sample under a microscope to see if it contains mesothelioma cells and identify the cell type (epithelioid, sarcomatoid, or biphasic).

Talking to your doctor about mesothelioma can be overwhelming. Download our Free Checklist of Questions to Ask Your Doctor and get the clarity you need to understand your health and next steps.

14 Questions to Ask Your Doctor packet
Free Download: 14 Questions to Ask Your Doctor
  • Preparing for treatment
  • Finding clinical trials
  • Getting a second opinion

Get Your Free Download

Epithelioid Mesothelioma Subtypes

There are several subtypes of epithelioid mesothelioma that can be harder to treat. Most of these cell subtypes are rare and affect a very small number of patients.

These rare subtypes include:
  • Adenomatoid: This subtype makes up roughly 6% of epithelioid pleural mesothelioma cases.
  • Cystic: The cystic cell subtype is typically benign (not cancerous) and found in women with peritoneal mesothelioma.
  • Deciduoid: This cell subtype is diagnosed in 5% of mesothelioma patients.
  • Lymphohistiocytoid: Only a few lymphohistiocytoid mesothelioma cases have ever been reported (less than 1%).
  • Small-cell: This extremely rare subtype is often mistaken for other small-cell cancers.
  • Solid: This subtype forms in patterns that look like sheets or nests and has an average prognosis of just over 1 year.
  • Tubulopapillary: Patients with these cube-shaped cells have an average prognosis of almost 2 years.
  • Well-differentiated papillary: Papillary mesothelioma cells are more common in women than men and do not spread quickly.

Your doctor can check your biopsy results to see if you have one of these epithelial subtypes and adjust your treatment plan accordingly.

Epithelioid Mesothelioma Life Expectancy and Prognosis

The average life expectancy for epithelioid mesothelioma is nearly 2 years with surgery. Compared to the other two cell types, epithelial mesothelioma has a better health outlook since it’s less aggressive and responds better to treatments.

Mesothelioma Cell TypeMedian Survival With Surgery
Epithelioid22.2 months
Sarcomatoid12.4 months
Biphasic6.4 months

Epithelial patients who get surgery after radiation therapy have an average prognosis of 36 months, according to a study published in Communications Biology.

“When it comes to mesothelioma, the epithelioid type tends to have a better outlook than other cell types. That means there’s more reason to stay positive and hopeful about treatment possibilities.”

Jenna Tozzi, RN, Chief Patient Care Advisor for Mesothelioma Hope

What Is the Epithelial Mesothelioma Survival Rate?

Survival rate is the percentage of people who are still alive a certain number of years after a mesothelioma diagnosis.

The table below provides overall survival rates for epithelioid mesothelioma with different treatment options.

Treatment Type2-Year Survival Rate5-Year Survival Rate
Surgery45%14%
Chemotherapy35%9%
Radiotherapy40%12%
Immunotherapy37%7%
Surgery and Chemotherapy45%15%
Source: National Cancer Database (NCDB)

These survival rates show how treatments have worked for others, but everyone’s situation is different. Your age, cancer stage, and other factors can affect your epithelioid mesothelioma prognosis. While survival rates provide helpful insights, they don’t define your future.

Get our Free Mesothelioma Guide shipped overnight to learn more about improving your prognosis and life expectancy.

Epithelial Mesothelioma Treatment Options

Treatment for epithelioid mesothelioma typically includes options like surgery, chemotherapy, immunotherapy, and radiation. Many patients benefit from multimodal therapy, which combines two or more different treatments to target the cancer.

Some of these treatments can also serve as palliative care to reduce symptoms and improve quality of life.

Surgery

Mesothelioma patients with the epithelioid cell type are more likely to qualify for surgery than those with sarcomatoid or biphasic cells.

Surgeries for epithelial mesothelioma include:

In a recent study, P/D surgery was more effective than EPP surgery for pleural epithelioid mesothelioma. Patients who got a P/D lived over 2.5 years, and patients who underwent an EPP lived just 1.5 years.

“Typically for epithelioid mesothelioma, we offer surgery up front, followed by adjuvant chemotherapy or immunotherapy.”

Dr. Deepa Magge, mesothelioma specialist

Chemotherapy

Chemotherapy uses cancer-fighting drugs to shrink mesothelioma tumors and kill cancer cells.

The most common chemotherapy regimen for epithelioid mesothelioma is pemetrexed with cisplatin or carboplatin.

Most patients receive multiple rounds of mesothelioma chemotherapy with a few weeks off between treatments so they can recover.

Immunotherapy

Mesothelioma immunotherapy helps the body’s immune system better identify and attack cancer cells.

Three immunotherapy drugs are approved to treat epithelioid mesothelioma:

Other immunotherapy drugs are being tested in clinical trials to see if they can help epithelioid mesothelioma patients live longer.

Did You Know?

According to a recent case study, one patient went into complete remission from epithelioid peritoneal mesothelioma with Keytruda and chemotherapy.

This means all signs and symptoms of his cancer disappeared. The patient is still in remission more than 4 years later.

Radiation Therapy

Radiation therapy uses powerful high-energy rays to destroy cancer cells by damaging their DNA.

Doctors often recommend this treatment to shrink tumors before surgery or to manage symptoms if the cancer is unresectable (inoperable).

Get our Free Mesothelioma Guide to learn more about the latest treatments that could improve your prognosis and quality of life.

Mesothelioma Guide Images
Get Your Free 2025 Mesothelioma Guide
  • Symptoms & staging
  • Average prognosis
  • Life-extending treatments

Get Your Free Guide

Emerging Treatments in Clinical Trials

New and innovative treatments for epithelioid mesothelioma are being tested in clinical trials. These emerging treatments could potentially help patients live longer with fewer symptoms.

Some of these emerging treatments include:

Your doctor can help determine if a clinical trial is right for you. Our Patient Advocates are also available to guide you through the process.

Find Epithelioid Mesothelioma Treatment

If you’ve been diagnosed with epitheloid mesothelioma, having the right medical team by your side is crucial for your treatment and recovery.

Mesothelioma Hope can help make the process of starting treatment as straightforward and easy as possible. Our dedicated team is here to guide you every step of the way, from connecting you with the right specialist to preparing you for your first appointment.

Call us today at (866) 608-8933 or get our Free Mesothelioma Guide shipped overnight to learn more about how we can help.

Mesothelioma Epithelioid Type FAQs

What is the cause of epithelioid mesothelioma?

Exposure to asbestos is the only known cause of epithelioid mesothelioma.

When you breathe in or swallow asbestos fibers, they can get stuck in the lining of the lungs, abdomen, or heart, causing inflammation. This can damage healthy cells and cause mesothelioma cancer to develop after 10 to 50 years.

What are the stages of epithelioid mesothelioma?

There are four epithelioid mesothelioma stages:

  • Stage 1: The tumor is small and hasn’t spread to lymph nodes or other parts of the body.
  • Stage 2: The tumor is larger or has spread to nearby lymph nodes but hasn’t spread to other areas of the body.
  • Stage 3: The cancer is more advanced, with a larger tumor and possible spread to nearby tissues or multiple lymph nodes.
  • Stage 4: Cancer has spread to other parts of the body (metastasis).

These stages help doctors understand how far the cancer has progressed and what types of treatment are best for each patient.

What is the survival rate for epithelioid mesothelioma?

The survival rate for epithelioid mesothelioma varies depending on the stage of the disease, the overall health of the patient, and the specific treatments used.

  • With chemotherapy, 35% of patients survive 2 years, and 9% survive over 5 years.
  • With immunotherapy and chemotherapy, 37% of patients survive 2 years, and 7% survive over 5 years.
  • With chemotherapy and surgery, 45% of patients survive 2 years, and 15% survive over 5 years.

Is epithelioid mesothelioma curable?

While epithelioid mesothelioma is a serious and challenging cancer, multimodal therapy may help slow it down or stop it from spreading. Some patients have even achieved remission from epithelial mesothelioma, meaning their cancer is no longer detectable.

The key to surviving mesothelioma is starting treatment with a specialist as early as possible. Contact our team today to connect with the best mesothelioma doctors near you.

Dr. Mark LevinReviewed by:Mark Levin, MD

Certified Oncologist and Hematologist

  • Fact-Checked
  • Editor

Mark Levin, MD, has over 30 years of experience in academic and community hematology and oncology. In addition to serving as Chief or Director at four different teaching institutions throughout his life, he is still a practicing clinician, has taught and designed formal education programs, and has authored numerous publications in various fields related to hematology and oncology.

Dr. Mark Levin is an independently paid medical reviewer.

  • Board Certified Oncologist
  • 30+ Years Experience
  • Published Medical Author
Jenna TozziWritten by:

Chief Patient Care Advisor

Jenna Tozzi, RN, is the Chief Patient Care Advisor for Mesothelioma Hope. With more than 15 years of experience as an adult and pediatric oncology nurse navigator, Jenna provides exceptional guidance and support to cancer patients and their loved ones. Jenna has been featured in Oncology Nursing News and is a member of the Academy of Oncology Nurse & Patient Navigators & the American Nurses Association.

Our Promise to You
Our Promise to You
References
  1. Allen, T. C. (2005). Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies. Archives of Pathology & Laboratory Medicine, 129(11), 1415. Retrieved January 8, 2025, from https://pubmed.ncbi.nlm.nih.gov/16253022/
  2. American Cancer Society. (n.d.). Surgery  for Malignant Mesothelioma. Retrieved January 8, 2025, from https://www.cancer.org/cancer/malignant-mesothelioma/treating/surgery.html
  3. Balduyck, B., MD, et al. (2010). Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: Is it really worthwhile? Annals of Thoracic Surgery, 89(3), 907-911. Retrieved January 8, 2025, from https://pubmed.ncbi.nlm.nih.gov/16253022/
  4. Disease Dynamic Trial Listing Page. (n.d.). Retrieved January 8, 2025, from https://www.cancer.gov/about-cancer/treatment/clinical-trials/disease/mesothelioma/treatment
  5. Dr. Biology. (2011, February 16). Epithelial Cells. ASU – Ask A Biologist. Retrieved January 8, 2025, from https://askabiologist.asu.edu/epithelial-cells
  6. Husain, A. N., et al. (2009). Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the international mesothelioma interest group. Archives of Pathology & Laboratory Medicine, 133(8), 1317. Retrieved January 8, 2025, from https://pubmed.ncbi.nlm.nih.gov/28686500/
  7. Mesothelioma: Diagnosis. (n.d.). Retrieved January 8, 2025, from https://www.cancer.net/cancer-types/mesothelioma/diagnosis
  8. Mesothelioma: Types of Treatment. (n.d.). Retrieved January 8, 2025, from https://www.cancer.net/cancer-types/mesothelioma/types-treatment
  9. Meyerhoff, Robert Ryan et al. “Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.” The Journal of surgical research vol. 196,1 (2015): 23-32. doi:10.1016/j.jss.2015.01.043. Retrieved January 8, 2025, from https://pubmed.ncbi.nlm.nih.gov/25791825/
  10. Mott, F. E. (2012). Mesothelioma: A review. The Ochsner Journal, 12(1), 70-79. Retrieved January 8, 2025, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307510/
  11. NCI Dictionary of Cancer Terms. (n.d.). Retrieved January 8, 2025, from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/sarcomatoid-carcinoma
  12. Stevers, M., et al. (2019). Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, 32(1), 88-99. Retrieved January 8, 2025, from https://pubmed.ncbi.nlm.nih.gov/30171198/
  13. Sugarbaker, D. J., et al. (1996). Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Annals of surgery, 224(3), 288–296. Retrieved SJanuary 8, 2025, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1235368/
  14. Swedish Cancer Institute (Director). (2010, September 29). Mesothelioma and Malignant Pleural Issues [Video file]. Retrieved January 8, 2025, from https://www.youtube.com/watch?v=gJr71tbBnpI
  15. Van Zandwijk, N., et al. (2013). Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. Journal of Thoracic Disease, 5(6), E254-E307. Retrieved January 8, 2025, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886874/
Free 30-Minute ConversationWith Jenna Tozzi, RN
Fill Out Your Contact Information
I understand by submitting this form that I am providing my consent to be contacted by Mesothelioma Hope and its co-counsel, potentially using automated technology, at the number provided regarding my potential claim/their services. Consent is not required to use their services. Msg frequency varies, and message and data rates may apply. Reply HELP for help or STOP to unsubscribe. SMS Terms of Service. I understand and agree that by submitting this form I agree to the Privacy Policy and Terms of Use and that this form does not create an attorney-client relationship and is not confidential or privileged and may be shared.
Get Help Connecting With Epithelioid Mesothelioma
I understand by submitting this form that I am providing my consent to be contacted by Mesothelioma Hope and its co-counsel, potentially using automated technology, at the number provided regarding my potential claim/their services. Consent is not required to use their services. Msg frequency varies, and message and data rates may apply. Reply HELP for help or STOP to unsubscribe. SMS Terms of Service. I understand and agree that by submitting this form I agree to the Privacy Policy and Terms of Use and that this form does not create an attorney-client relationship and is not confidential or privileged and may be shared.
How We Can Help

Mesothelioma Hope is passionate about helping patients and families affected by this aggressive cancer. A mesothelioma diagnosis can be scary and isolating, but we’re here for you at every step. Hope is only a phone call away.

(866) 608-8933
Medical Guidance
  • Get a second opinion
  • Find a doctor or cancer center
  • Access clinical trials
  • Improve your quality of life
Financial Assistance
  • Access $30 billion in trust funds
  • File a mesothelioma claim
  • Increase your VA benefits
  • Apply for travel grants
Supportive Care
  • Find a support group or peer mentor
  • Get help with daily tasks
  • Explore respite care options
  • Navigate life post-treatment